Table 1.
Cytoplasmic Dicer staining
|
Total | p value* | |||
---|---|---|---|---|---|
Negative | Weak | Strong | |||
Age | |||||
≤62 | 15 (11.2%) | 31 (23.1%) | 88 (65.7%) | 134 | 0.702 |
>62 | 15 (11.7%) | 35 (27.3%) | 78 (61.0%) | 128 | |
Sex | |||||
Male | 23 (16.7%) | 32 (23.2%) | 83 (60.1%) | 138 | 0.009 |
Female | 6 (4.8%) | 35 (28.2%) | 83 (67.0%) | 124 | |
Tumor thickness (mm) | |||||
≤2 mm | 12 (8.2%) | 34 (23.1%) | 101 (68.7%) | 147 | 0.073 |
>2mm | 18 (15.7%) | 32 (27.8%) | 65 (56.5%) | 115 | |
Ulceration | |||||
Present | 8 (14.8%) | 14 (25.9%) | 32 (59.3%) | 54 | 0.648 |
Absent | 22 (10.6%) | 52 (25.0%) | 134 (64.4%) | 208 | |
Lymphocytic response | |||||
Present | 12 (12.8%) | 15 (15.9%) | 67 (71.3%) | 94 | 0.036 |
Absent | 18 (10.7%) | 51 (30.4%) | 99 (58.9%) | 168 | |
Tumor subtype | |||||
Lentigo maligna | 10 (21.3%) | 9 (19.1%) | 28 (59.6%) | 47 | 0.256 |
Superficial spreading | 8 (8.8%) | 24 (26.4%) | 59 (64.8%) | 91 | |
Nodular | 5 (10.9%) | 9 (19.6%) | 32 (69.5%) | 46 | |
Other† | 7 (9.0%) | 24 (30.8%) | 47 (60.2%) | 78 | |
Site‡ | |||||
Sun-exposed | 13 (13.8%) | 22 (23.4%) | 59 (62.8%) | 94 | 0.632 |
Sun-protected | 17 (10.1%) | 44 (26.2%) | 107 (63.7%) | 168 |
χ2 test.
Other: unspecified subtype.
Sun-protected sites: trunk, arm, leg and feet; Sun-exposed sites: head and neck.